Taiwania Capital — Activity | F4

Team Portfolio Raise Read Contact

F4/Taiwania Capital/Activity

Taiwania Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· SEP 2025 – MAR 2026Show all

Investment

Taiwania's CEE Fund joined Orqa's €12.7 million Series A to support a resilient non-Chinese UAV supply chain.

Orqa

Orqa Taiwania Capital

taiwaniacapital.comMAR 18, 2026

MAR 18, 2026

Investment

The TaiAx life science joint venture led Rakuten Medical's $100 million Series F.

Rakuten Medical

Rakuten Medical Taiwania Capital

taiwaniacapital.comJAN 7, 2026

JAN 7, 2026

Investment

Taiwania led Supernova's $9.2 million Series A to scale its design-to-code platform.

Supernova

Supernova Taiwania Capital

taiwaniacapital.comSEP 30, 2025

SEP 30, 2025

New Fund

Taiwania and Axil Capital launched TaiAx Life Science Fund L.P. to back life science innovation.

TaiAx Life Science Fund L.P.

Taiwania Capital

taiwaniacapital.comAUG 27, 2024

AUG 27, 2024

Exit

Repligen announced an agreement to acquire Tantti Laboratory, marking a portfolio exit.

Tantti Laboratory

Tantti LaboratoryTaiwania Capital

taiwaniacapital.comJUL 31, 2024

JUL 31, 2024

Investment

Taiwania made a strategic investment in TransferGo to support Asia-Pacific growth.

TransferGo

TransferGo Taiwania Capital

taiwaniacapital.comAPR 11, 2024

APR 11, 2024

Investment

Taiwania led APrevent Medical's $6 million Series D funding round.

APrevent Medical

APrevent Medical Taiwania Capital

taiwaniacapital.comAPR 2, 2024

APR 2, 2024